Unitree warns of humanoid robot commercialization and valuation risks
AI summary
IT之家, citing Unitree Technology's abnormal stock-trading announcement, said the humanoid robot industry remains at an early commercialization stage, with uncertainty in technical maturity, downstream demand development, and supply-chain readiness. The company said its closing-price gain deviation cumulatively exceeded 30% over three consecutive trading days, and its trailing P/E reached 388.25 as of October 20, 2026.
In-depth insight
The announcement warns that slower-than-expected large-scale commercialization could adversely affect Unitree's future revenue expansion and performance, creating a risk of valuation reversion.